Google News

Ozempic Patent Expiry Heralds Weight-Loss Drug Boom in India  Bloomberg.comWhat Are Semaglutide Generics? Here's Why They Matter More In India Now  NDTVNovo Nordisk Patent Loss In India Tests GLP 1 Valuation Story  Yahoo FinanceNew Drug Semaglutide Discussed at Patna’s “Walk for Life” Diabetes Awareness Event  Patna PressIndian Semaglutide Generics Test Novo Nordisk’s Pricing Power And Growth Story  simplywall.st